Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 555 JPY 4.59% Market Closed
Market Cap: 128B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Torii Pharmaceutical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Torii Pharmaceutical Co Ltd
Operating Income Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Operating Income
ÂĄ6.7B
CAGR 3-Years
21%
CAGR 5-Years
16%
CAGR 10-Years
4%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Income
ÂĄ403B
CAGR 3-Years
-17%
CAGR 5-Years
13%
CAGR 10-Years
12%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Income
ÂĄ260.5B
CAGR 3-Years
51%
CAGR 5-Years
19%
CAGR 10-Years
7%
Otsuka Holdings Co Ltd
TSE:4578
Operating Income
ÂĄ353.6B
CAGR 3-Years
19%
CAGR 5-Years
33%
CAGR 10-Years
5%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Income
ÂĄ540.2B
CAGR 3-Years
15%
CAGR 5-Years
24%
CAGR 10-Years
21%
Astellas Pharma Inc
TSE:4503
Operating Income
ÂĄ130.6B
CAGR 3-Years
-1%
CAGR 5-Years
-13%
CAGR 10-Years
-1%

See Also

What is Torii Pharmaceutical Co Ltd's Operating Income?
Operating Income
6.7B JPY

Based on the financial report for Jun 30, 2024, Torii Pharmaceutical Co Ltd's Operating Income amounts to 6.7B JPY.

What is Torii Pharmaceutical Co Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
4%

Over the last year, the Operating Income growth was 53%. The average annual Operating Income growth rates for Torii Pharmaceutical Co Ltd have been 21% over the past three years , 16% over the past five years , and 4% over the past ten years .

Back to Top